menu
    • menu

    Company profile for Ascentage Pharma

    NEW Drugs in Dev: 13
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Leveraging our expertise in structure-based drug design and our innovative drug discovery engine, we have developed a robust pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions (PPIs), and next-genera...
    Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Leveraging our expertise in structure-based drug design and our innovative drug discovery engine, we have developed a robust pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions (PPIs), and next-generation tyrosine kinase inhibitors (TKIs).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ascentage PharmaChina Flag
    Country
    Country
    China
    Address
    Address
    218 Xinghu Street, Building B7, 7th Floor, Suzhou Industrial Park, Suzhou, Jia...
    Telephone
    Telephone
    +86-512-85557777
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ascentagepharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ascentage-pharma-group-corporation
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascentage Pharma Joins Three Investor Conferences
    Ascentage Pharma Joins Three Investor Conferences

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242582/0/en/Ascentage-Pharma-to-Participate-in-Three-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Ascentage Pharma Joins Guggenheim Biotech Summit 2026
    Ascentage Pharma Joins Guggenheim Biotech Summit 2026

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234476/0/en/Ascentage-Pharma-to-Participate-in-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Ascentage Announces IND Clearance by China CDE for APG-3288
    Ascentage Announces IND Clearance by China CDE for APG-3288

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3233530/0/en/Ascentage-Pharma-Announces-IND-Clearance-by-the-China-CDE-for-BTK-Degrader-APG-3288.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    Ascentage Pharma Shares Innovation Strategy at J.P. Morgan Conf
    Ascentage Pharma Shares Innovation Strategy at J.P. Morgan Conf

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219202/0/en/Ascentage-Pharma-Outlined-its-Global-Innovation-Strategy-During-Presentation-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    Ascentage Pharma Secures FDA IND Clearance for BTK Degrader
    Ascentage Pharma Secures FDA IND Clearance for BTK Degrader

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214213/0/en/Ascentage-Pharma-Announces-IND-Clearance-by-the-U-S-Food-and-Drug-Administration-for-BTK-Degrader-APG-3288.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Ascentage Pharma at 44th J.P. Morgan Healthcare Conference
    Ascentage Pharma at 44th J.P. Morgan Healthcare Conference

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206945/0/en/Ascentage-Pharma-to-Present-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search